Maintenance Vitamin D Therapy for Secondary Hyperparathyroidism (2HPT)
NCT00828347
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
35
Enrollment
OTHER
Sponsor class
Conditions
Secondary Hyperparathyroidism
Interventions
DRUG:
1.0 μg/day Alfacalcidol
DRUG:
0.25 μg/day Alfacalcidol
Sponsor
Kumamoto University